PURPOSE: Usher syndrome is a major cause of genetic deafness and blindness. The hearing loss is usually congenital and the retinitis pigmentosa is progressive and first noticed in early childhood to the middle teenage years. Its frequency may be underestimated. Newly developed molecular technologies can detect the underlying gene mutation of this disorder early in life providing estimation of its prevalence in at risk pediatric populations and laying a foundation for its incorporation as an adjunct to newborn hearing screening programs. METHODS: A total of 133 children from two deaf and hard of hearing pediatric populations were genotyped first for GJB2/6 and, if negative, then for Usher syndrome. Children were scored as positive if the test revealed > or =1 pathogenic mutations in any Usher gene. RESULTS: Fifteen children carried pathogenic mutations in one of the Usher genes; the number of deaf and hard of hearing children carrying Usher syndrome mutations was 15/133 (11.3%). The population prevalence was estimated to be 1/6000. CONCLUSION: Usher syndrome is more prevalent than has been reported before the genome project era. Early diagnosis of Usher syndrome has important positive implications for childhood safety, educational planning, genetic counseling, and treatment. The results demonstrate that DNA testing for Usher syndrome is feasible and may be a useful addition to newborn hearing screening programs.
PURPOSE: Usher syndrome is a major cause of genetic deafness and blindness. The hearing loss is usually congenital and the retinitis pigmentosa is progressive and first noticed in early childhood to the middle teenage years. Its frequency may be underestimated. Newly developed molecular technologies can detect the underlying gene mutation of this disorder early in life providing estimation of its prevalence in at risk pediatric populations and laying a foundation for its incorporation as an adjunct to newborn hearing screening programs. METHODS: A total of 133 children from two deaf and hard of hearing pediatric populations were genotyped first for GJB2/6 and, if negative, then for Usher syndrome. Children were scored as positive if the test revealed > or =1 pathogenic mutations in any Usher gene. RESULTS: Fifteen children carried pathogenic mutations in one of the Usher genes; the number of deaf and hard of hearing children carrying Usher syndrome mutations was 15/133 (11.3%). The population prevalence was estimated to be 1/6000. CONCLUSION: Usher syndrome is more prevalent than has been reported before the genome project era. Early diagnosis of Usher syndrome has important positive implications for childhood safety, educational planning, genetic counseling, and treatment. The results demonstrate that DNA testing for Usher syndrome is feasible and may be a useful addition to newborn hearing screening programs.
Authors: Paul A Sieving; Rafael C Caruso; Weng Tao; Hanna R Coleman; Darby J S Thompson; Keri R Fullmer; Ronald A Bush Journal: Proc Natl Acad Sci U S A Date: 2006-02-27 Impact factor: 11.205
Authors: Artur V Cideciyan; Samuel G Jacobson; Tomas S Aleman; Danian Gu; Susan E Pearce-Kelling; Alexander Sumaroka; Gregory M Acland; Gustavo D Aguirre Journal: Proc Natl Acad Sci U S A Date: 2005-03-22 Impact factor: 11.205
Authors: Ronald J E Pennings; Vedat Topsakal; Lisa Astuto; Arjan P M de Brouwer; Mariette Wagenaar; Patrick L M Huygen; William J Kimberling; August F Deutman; Hannie Kremer; Cor W R J Cremers Journal: Otol Neurotol Date: 2004-09 Impact factor: 2.311
Authors: Saima Riazuddin; Sabiha Nazli; Zubair M Ahmed; Yi Yang; Fareeha Zulfiqar; Rehan S Shaikh; Ahmed U Zafar; Shaheen N Khan; Farooq Sabar; Fouzia T Javid; Edward R Wilcox; Ekaterini Tsilou; Erich T Boger; James R Sellers; Inna A Belyantseva; Sheikh Riazuddin; Thomas B Friedman Journal: Hum Mutat Date: 2008-04 Impact factor: 4.878
Authors: Uirá S Melo; Silvana Santos; Hannalice G Cavalcanti; Wagner T Andrade; Vitor G Dantas; Marine Rd Rosa; Regina C Mingroni-Netto Journal: Int J Mol Epidemiol Genet Date: 2014-02-17
Authors: Maryam Beheshtian; Mojgan Babanejad; Hela Azaiez; Niloofar Bazazzadegan; Diana Kolbe; Christina Sloan-Heggen; Sanaz Arzhangi; Kevin Booth; Marzieh Mohseni; Kathy Frees; Mohammad Hossein Azizi; Ahmad Daneshi; Mohammad Farhadi; Kimia Kahrizi; Richard Jh Smith; Hossein Najmabadi Journal: Arch Iran Med Date: 2016-10-01 Impact factor: 1.354